Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.78B |
| 2 |
Microsoft
MSFT
|
+$2.22B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.67B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.65B |
| 5 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.19B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.45B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$533M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$410M |
| 4 |
Stellantis
STLA
|
+$312M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.28% |
| 2 | Healthcare | 11.27% |
| 3 | Financials | 10.52% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3426
Hovnanian Enterprises
HOV
$726M
| $94.9K | ﹤0.01% |
957
-1,491
| -61% | -$123K |
|
3427
Oportun Financial
OPRT
$255M
| $94.8K | ﹤0.01% |
15,881
-20,155
| -56% | -$98.9K |
|
|
ASRT
3428
DELISTED
Assertio
ASRT
| $94.3K | ﹤0.01% |
1,160
-7,257
| -86% | -$674K |
|
3429
SES AI
SES
$203M
| $94.2K | ﹤0.01% |
+38,615
| New | +$74.8K |
|
|
ENFN
3430
DELISTED
Enfusion, Inc.
ENFN
| $94K | ﹤0.01% |
8,379
-5,243
| -38% | -$46.5K |
|
|
NOA
3431
North American Construction
NOA
$369M
| $93.9K | ﹤0.01% |
4,907
+4,526
| +1,188% | +$85K |
|
3432
State Street SPDR S&P Aerospace & Defense ETF
XAR
$5.93B
| $93.6K | ﹤0.01% |
770
+100
| +15% | +$11.6K |
|
3433
Monte Rosa Therapeutics
GLUE
$1.4B
| $93.4K | ﹤0.01% |
13,635
-1,534
| -10% | -$9.92K |
|
3434
Vivid Seats
SEAT
$84.6M
| $93.4K | ﹤0.01% |
589
-59
| -9% | -$9.2K |
|
3435
Forum Energy Technologies
FET
$708M
| $93.2K | ﹤0.01% |
3,644
-6,251
| -63% | -$148K |
|
3436
Costamare
CMRE
$1.88B
| $93.1K | ﹤0.01% |
9,629
-17,208
| -64% | -$154K |
|
3437
Rimini Street
RMNI
$449M
| $92.5K | ﹤0.01% |
19,312
-5,770
| -23% | -$23.9K |
|
3438
NVE Corp
NVEC
$562M
| $92.4K | ﹤0.01% |
948
-3,176
| -77% | -$275K |
|
3439
Tredegar Corp
TG
$265M
| $92K | ﹤0.01% |
13,795
-326
| -2% | -$2.58K |
|
3440
Legacy Housing
LEGH
$625M
| $91.9K | ﹤0.01% |
3,965
-515
| -11% | -$11.2K |
|
3441
C4 Therapeutics
CCCC
$385M
| $91.8K | ﹤0.01% |
33,368
-13,995
| -30% | -$45K |
|
|
CVLY
3442
DELISTED
Codorus Valley Bancorp Inc
CVLY
| $90.5K | ﹤0.01% |
4,615
+67
| +1% | +$1.27K |
|
3443
Kenon Holdings
KEN
$3.51B
| $89.9K | ﹤0.01% |
+3,872
| New | +$104K |
|
3444
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.1B
| $89.3K | ﹤0.01% |
540
-2,621
| -83% | -$413K |
|
3445
Quantum-Si Incorporated
QSI
$155M
| $89.1K | ﹤0.01% |
49,777
-26,358
| -35% | -$41.3K |
|
3446
VEON
VEON
$3.62B
| $88.3K | ﹤0.01% |
4,320
| – | – |
|
3447
Choiceone Financial
COFS
$509M
| $88.2K | ﹤0.01% |
3,836
+1,398
| +57% | +$32.4K |
|
3448
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$11.5B
| $87.8K | ﹤0.01% |
+2,735
| New | +$88.3K |
|
3449
SIGA Technologies
SIGA
$235M
| $87.4K | ﹤0.01% |
17,311
-7,540
| -30% | -$42.9K |
|
3450
Vroom Inc
VRM
$39M
| $87.4K | ﹤0.01% |
758
-10,638
| -93% | -$811K |
|
Similar funds
Barclays's Q2 2023 Portfolio in Review
As of Q2 2023, Barclays held 5,371 positions worth $158B, down 28% from $218B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays withdrew a net $70.1B in Q2 2023, closing 872 positions and reducing 1,669 holdings. Its most notable exit was DCP Midstream, LP, an estimated $47.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in State Street SPDR Nuveen ICE Municipal Bond ETF worth $36.9M.
- Barclays's largest Q2 2023 buy was State Street SPDR Nuveen ICE Municipal Bond ETF: 799,988 shares worth $36.9M.
- Barclays added most to Apple in Q2 2023, an estimated $2.78B increase.
- Barclays's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.45B.
- Barclays fully exited DCP Midstream, LP in Q2 2023, selling an estimated $47.3M.
- Barclays's ten largest holdings make up 24% of its $158B portfolio in Q2 2023.
- Barclays opened 314 new positions and closed 872 in Q2 2023.
- Barclays's portfolio value fell 28% quarter-over-quarter to $158B.
Based on Barclays's 13F filing for Q2 2023, filed 3 Aug 2023.